All lobbying filings

The KPM Group DC LLC

The KPM Group DC LLC filed a Q1 report for Soleno Therapeutics, Inc. on April 20, 2026, reporting $20,000 in lobbying income.

Lobbying for Soleno Therapeutics, Inc. · Soleno is focused on development of novel therapeutics for treatment of rare diseases.

As filed: THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.

All filings by The KPM Group DC LLC · Everything Soleno Therapeutics, Inc. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

H.R.7118, Genomic Answers for Childrens Health Act H.R.1414, Camerons Law H.R.1492/S.832, EPIC Act S.3019, No Big Blockbuster Bailouts Act

Bills named in this filing 5

H.R. 7118
Genomic Answers for Children’s Health Act of 2026
H.R. 1414
Cameron’s Law
H.R. 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
S. 832
EPIC Act of 2025
S. 3019
No Big Blockbuster Bailouts Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.